Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.6200
+0.0390 (6.71%)
Apr 28, 2025, 10:36 AM EDT - Market open
Incannex Healthcare Revenue
Incannex Healthcare had revenue of $12.00K in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to $98.00K. In the fiscal year ending June 30, 2024, Incannex Healthcare had annual revenue of $12.00K.
Revenue (ttm)
$98.00K
Revenue Growth
n/a
P/S Ratio
100.85
Revenue / Employee
$10,889
Employees
9
Market Cap
17.08M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
IXHL News
- 25 days ago - Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - GlobeNewsWire
- 7 weeks ago - Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025 - Newsfile Corp
- 2 months ago - Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board - GlobeNewsWire
- 3 months ago - Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - GlobeNewsWire
- 5 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Newsfile Corp
- 5 months ago - Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire